Amarin Corp Plc (AMRN)

[JRoon71]

RMB, go back to some of Sleven's earlier comments on BRAVE. He makes some great points about the study and how the FDA is treating ALZ studies.

Keep in mind, it's not an outcome study, it's a biomarker study. They aren't trying to show a "cure" (ie. patient outcome) in this trial. They are trying to show changes in biomarkers. And they don't need 6 years and 10,000 patients to show biomarker impact.